MSD and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50% for Patients with Mild or Moderate COVID-19
At the Interim Analysis, 7.3 Percent of Patients Who Received Molnupiravir Were Hospitalized Through Day 29, Compared With 14.1 Percent of Placebo-Treated Patients Who were Hospitalized or Died MSD and Ridgeback Announce Submission of Emergency Use Authorization...
QF RESEARCHERS PARTICIPATE IN GLOBAL GENOMIC STUDY THAT RELEASES FINDINGS FOR POTENTIAL THERAPIES IN COVID-19 PATIENTS
Researchers from Qatar Foundation Research, Development, and Innovation’s Qatar Genome Programme contribute toward global initiative that can lead to therapeutic targets in addition to the protection conferred by the vaccines Beirut, Lebanon, August 10, 2021: In March...
Saudi German Health Advances Digital Healthcare Services with Nutanix
Healthcare provider deploys Nutanix HCI and Nutanix Prism Pro that have enabled cost savings, eased complexity of management, enhanced reliability and scalability of IT environment and provided a platform for introduction of innovative digital services Nutanix, Inc....
Ericsson takes 5G live for developers at Google
Developers from around the world are getting a taste of 5G as Ericsson brings live 5G network coverage to the annual Google I/O event taking place in Mountain View, California, US on May 7-9. Google has selected Ericsson as sole 5G infrastructure provider for this...